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Solitary ﬁbrous tumors (SFT) are rare tumors ﬁrst reported in the
pleural tissue of the thoracic cavity. They were originally thought to
be limited to mesothelial surfaces but there are now reports of over
100 extrathoracic SFTs occurring in soft tissues of the extremities
and genital tract. Hemangiopericytoma is frequently classiﬁed as a
histologic subset of SFTs distinguished by its branching vascular pat-
tern but in fact they may be synonymous. Historically these benign
tumors have been found in the genital soft tissue of both genders.
At the time of this patient's presentation only 9 SFTs within the
female genital tract had been reported (Biedrzycki et al., 2007). This
case report marks the ﬁfth case of primary vulvar SFT. Comparative
pathologic ﬁndings after surgical treatment are hereby reviewed.
Case report
Our patient is a 60 year-old Caucasian woman who presented to
her gynecologist with a 4 month history of an enlarging vulvar mass
that caused discomfort in the seated position. Attempted incision
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Open access under CC BY-NC-ND license .structure without any ﬂuid or purulence. Empiric antibiotics were
prescribed. On presentation to gynecologic oncology service she was
afebrile, had no constitutional symptoms and reported minimal
cream-like drainage from the incision site. Past medical history was
remarkable only for 3 normal vaginal deliveries. Physical exam re-
vealed a ﬁrm, ﬁxed 5 cmmass in the vulva and the patient was sched-
uled for a right radical hemivulvectomy. A smooth, immobile mass
with strong ﬁbrous attachments to the fascia overlying the pubis
bone was completely excised with negative margins.
The deep margin of the surgical specimen was marked black for
submission to pathology. Frozen section was done on the tumor. Dur-
ing ﬁnal processing, representative sections were taken from the
gross specimen including random sections of mass with capsule, rep-
resentative sections, grossly uninvolved adipose tissue and represen-
tative sections of accompanying vulvar mucosa.
The gross specimen revealed a well-circumscribed, encapsulated,
tan-brown mass 4.5 cm in maximum dimension with a focal area of
possible necrosis. No capsular invasion was identiﬁed.
There were hemorrhagic changes to surrounding adipose tissue,
possibly from the attempted drainage.
Microscopic and stain examinations were performed in compli-
ance with CLIA 88 regulations. The sample for light microscopy was
ﬁxed in neutral buffered formalin and processed for routine histologic
examination. Immunohistochemical and FISH analysis was performed
using a single block and LSI SYT Dual-color Break-apart Probe. Stains
included: HBNKNC x6, Caldesmon x1, CAM 5.2 x1, CD10 x1, ANEG
Mouse x1, ANEG Rab x1, AE1/3 x1, Desmin x1, H&E Recut x1,
IBNKNC x3, IX18 x1, Myogenin x1, SMActin x1.
Microscopically, deep to the submucosa was old hemorrhage with
hemosiderin-laden macrophages and perilesional ﬁbrosis. The lesion
was comprised of spindle cells exhibiting intermixed hyper and
hypocellular morphologic growth pattern with staghorn, partially
hyalinized vessels. There was mitotic activity (3 per 20 HPF), necrosis
and hemorrhage. Margins were negative. Frozen section suggested
benign angioﬁbroblastoma or angioﬁbroma and ﬁnal pathologic diag-
nosis was solitary ﬁbrous tumor/hemangiopericytomawith low grade
malignant potential.
The specimen was sent to a regional soft tissue center of excellence
for evaluation. They noted variable cellularity and a prominent pericytic
pattern. Twomitoses/10 HPF and areas of true coagulative necrosis and
hemorrhage were noted in at least two slides. Immunohistochemical
analysis showed approximately 30% of cells was positive for prolifera-
tionmarker Ki-67.Markers CD99 and CD34were both strongly positive.
ER, bcl and CD10 were weakly and focally positive. AE1/AE3, Cam 5.2,
Myogenin, caldesmon, PR, SMA, CD31, Desmin, Factor VIII Is, CD117,
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an SFT with at least low grade malignant potential.
The patient remains disease free 30 months postoperatively.
Review methods
Literature search was performed in the PubMed database. MeSH
search terms for published case reports and reviews included
terms similar to those for this review: vulvar hemangiopericytoma,
extrathoracic, solitary ﬁbrous tumor, female genital tract, SFT. All
pertinent permutations of word roots and factorial combinations were
utilized in the search. Reports and articles pertaining to this case report
and this disease were reviewed. Those articles referenced within later
reviews were eliminated as independent references. Articles published
in languages other than Englishwere also eliminated. Referenceswithin
the articles reviewed were also evaluated and reviewed independently
for supporting evidence. The ten most pertinent and comprehensive
references were chosen inclusive of the most currently reported case
reports.
Discussion
Hemangiopericytoma is a neoplastic entity that has frequently
been mislabeled and misidentiﬁed in the literature. The term, coined
by Stout and Murray in 1942 to describe a tumor arising from
pericytes, is a sub classiﬁcation from the broader histological category
of SFT or localized ﬁbrous tumors. An SFT is characteristically spindle
cells with intermixed hyper and hypocellular morphologic growth
pattern. The histological variant hemangiopericytoma demonstrates
a thin-walled branching vascular pattern that may be described as
“staghorn” and having a prominent pericyctic pattern (Fletcher et al.,
2002).
The tumors' immunohistochemistry is critical in making the
current diagnosis. As in this patient, hemangiopericytomas typically
stain positive for ﬁbroblastic tumormarkers CD34 and CD99, are focally
positive for ER/bcl and negative for SMA and desmin (Biedrzycki et al.,
2007; Mosquera and Fletcher, 2009). The signiﬁcance of accurately
characterizing and identifying the lesion comes from theneed to further
stratify a patient's prognosis based on the variations inmorphology andTable 1
Clinicopathologic features of primary SFTs of the female genital tract (Biedrzycki et al., 200
Present
case
Vulval
SFT
Atypical
vulval SFT
Paraovarian
SFT
Pt age 60 45 70 33
Parity G3P2 P3 0 N/A
Max diameter (mm) 45 60 150 150
Symptomatic Yes No No Yes
F/U (mos) 21 3 9 96
Necrosis Yes No Yes No
Mitoses 3/20 HPF and
2/10 HPF
No 1/20 HPF b1/10 HPF
Hemangiopericytoma-like Yes No Yes Yes
Adipose tissue admixed Yes No Yes No
Vimentin NR +
Ki67 30%
CD34 + + + +
CD99/MIC2 + +
ER/PR ER+ − PR+
Bcl 2 + + +
Cytokeratin NR − − −
EMA − − −
SMA − − − −
Desmin − − − −
S100 − − − −
P53 NR b1%
MIB1 NR b1%
Sentinel lymph nodes ND ND ND ND
HPF=High power ﬁeld; ER=Estrogen receptor; PR=Progesterone receptor; NR=Not repimmunohistochemical proﬁle of an excised tumor. The literature has
demonstrated both malignant and benign case studies of these tumors
and has attempted to identify the speciﬁc characteristics of note in
the malignant and life threatening tumors so that patients may be
adequately informed and treated.
The overall consensus is that tumors with characteristics that
match those of our patient tend to be benign in nature. They are
slow growing, local masses causing little effect, if any on the “host”;
the worst being than mass effect. There are a few reports in the liter-
ature of tumors with similar but not identical characteristics as this
tumor causing more symptomotology and/or recurring locally
(Vallat-Decouvelaere et al., 1998). Even with these reports, such tu-
mors are still considered benign. The malignant SFTs which have
been reported have had alternative characteristics. In one report of
92 SFTs, 10 recurred. In addition to having similar histologic features
of benign SFTs, each of these with recurrence had at least one atypical
histologic feature including increased cellularity, areas of necrosis,
greater than 4 mitosis per 10 HPF (Vallat-Decouvelaere et al., 1998;
Daigeler et al., 2006). There is no gender differentiation or correlation
to either benign or malignant status. Since the last formal reporting of
these tumors in the female genital tract by Biedrzycki et al. (2007) addi-
tional reports of female genital tract SFTs have been published
(Sidebotham et al., 2009; He et al., 2010; Chu et al., 2006; Zubor et al.,
2007; Zanelli et al., 2010). However, only one additional report has
been published expanding the recognition of malignant progression of
SFTs. In their report, Mosquera et al., describe 8 cases of SFTswith histo-
logic dedifferentiation. In these cases, the tumor morphology included
distinct transition zones within the delineated tumor margin in which
the character of the cells was signiﬁcantly more comparable to known
malignant behaving tumors. The immunohistochemical proﬁle of
these dedifferentiated tumors included consistent mutation of the p53
gene as is seen in many carcinomas and loss of the CD34 positivity
which has characterized the benign SFTs. Four of these 8 tumors with
dedifferentiation developed recurrence and 3 patients died of their dis-
ease (Mosquera and Fletcher, 2009).
The immunohistochemical proﬁle of our patient's tumor is com-
pared against similar tumors previously reported in the literature in
Table 1. From this information it is clear that there is a lot of hetero-
geneity in the presentation of these primary SFTs of the female genital7).
Fallopian
tube SFT
Uterine
SFT
Vaginal
SFT1
Vaginal
SFT2
Pediatric cervical SFT
(Sidebotham et al., 2009)
32 78 66 34 14
P1 N/A N/A P2 G0P0
60 240 10 37 17
Yes Yes No Yes Yes
24 0.5
No Yes No No Not stated
No No No b1/50 HPF 0–3/HPF
Yes Yes
No No No No No
Focal + + +
+ + + + ++
− + −
ER/PR+
+ + + −
− − −
−
− − − − +
− − − −
− − − +
b1%
b1% b1% 5%
ND ND ND ND −
orted; ND=Not done.
Table 2
Clinical data on patients with atypical/malignant extrathoracic solitary ﬁbrous tumors (Mosquera and Fletcher, 2009; Vallat-Decouvelaere et al., 1998; Daigeler et al., 2006).
Pt age M/F Max diam
(mm)
Necrosis Mitoses per
10 HPF
CD34 CD99/O13 Bcl 2 ER/PR EMA SMA Desmin S100 Local recurr
(mon)
Distant mets
(mon)
Total F/U
(mon)
Status
at F/U
Present case – vulva 60 F 45 Yes1 3/20 HPF1 and
2/10 HPF1
+ + + ER+ − − − − No No 30 NED
Scalp 62 M 34 No 8/10 HPF1 − −/− ND ND + ND ND ND No No 42 NED
Lung 58 F 115 No 8/10 HPF1 + −/− ND ND ND ND ND ND Yes Contr lung, bone 58 AWD
Thoracic Wall 52 F 80 Yes 3/10 HPF1 + −/+ ND ND + ND ND ND No No 12 NED
Arms, Flexors 57 M NR Yes1 10/10 HPF1 + + ND ND − ND ND − Yes Axilla, upper arm 6 NED
Triceps 81 M 80 No1
No2
3.1/10 HPF1
4.6/10 HPF2
3+/3+ 2+/2+ ND ND −/− −/− −/− −/− Yes, 12,18 No 13 NED
Thigh, deep 76 M 80 Yes 12/10 HPF1 − −/+ ND ND + ND ND ND Yes Lung ND ND
68 F 170 Yes 14/10 HPF1 + −/+ ND ND + ND ND ND Yes Lung MS 8 DOD
Abd wall 50 F 19 No1 b1/10 HPF1 4+ 3+ ND ND − − − − No No 18 DOC
50 F 64 Yes 8/10 HPF1 − −/− ND ND − ND ND ND No No 12 NED
Retro-peritoneum (RP) 40 M 170 No 4.5/10 HPF1 +/NR ND ND ND − − − − Yes 12 Lung 12, liver 34 34 AWD
63 F 45 Yes1
No2
15/10 HPF1
2.2/10 HPF2
NR/− 1+/4+ ND ND NR/− NR/− NR/− NR/− Yes, 168 No 180 NED
70 F 100 Yes1 4.5/10 HPF1 4+ 4+ ND ND − − − − No No 10 NED
68 F 200 No 25/10 HPF1 − −/+ ND ND − ND ND ND NR NR 1 DOD
Omentum 40 M 90 Yes 9/10 HPF1 − −/ND ND ND − ND ND ND Yes Liver, lung 34 DOD
Sigmoid mesocolon 44 M NR No1
Yes2
3.2/10 HPF1
11/10 HPF2
4+/4+ ND/1+ ND ND ND/focal + −/− − −/− No Meso-appndx, liver, 24 24 AWD
Pelvis 71 M 200a Yes1 2.6/10 HPF1 4+/NR 4+/NR ND ND −/ND −ND −ND −ND No Lung, liver, 12 24 AWD
32 F NRb Yes2 5/10 HPF2 4+2 3+2 ND ND −2 −2 −2 −2 Yes, 72 No 84 NED
Para-testicular 62 M 130 Yes1
No2
b1/10 HPF1
15/10 HPF2
4+/NR 1+/ND ND ND −/− Focal+/− ND/− −/− No RP 16 16 Lost to F/U
Para-ovarian 33 F 150 No1
Yes2
b1/10 HPF1
6.8/10 HPF2
4+/+ 3+/4+ ND ND − −/focal + − − No Bone 72 Bone 96 Liver 96 96 AWD
All treated with complete surgical excision unless otherwise noted Primary1/Recurrent2. F/U=Follow up; MS=Mediastinum; HPF=High power ﬁeld; ER=Estrogen receptor; PR=Progesterone receptor; NR=Not reported; ND=Not
done; NED=no evidence of disease; AWD=alive with disease; DOD=dead of disease; DOC=dead of other cause.
a Marginal excision, chem.
b Incomplete surg excision, XRT.
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those tumors that have recurred and been found to have more malig-
nant activity are summarized in Table 2. The ﬁndings summarized
here are inconsistent and indicate that immunohistochemical proﬁle
alone is insufﬁcient to determine the prognosis for a given extrathoracic
SFT such as a vulvar hemangiopericytoma. As the above reports indi-
cate, the only consistent characterization amongmalignant type tumors
are atypia and increased mitoses (>4 per 10 HPF) which may correlate
with recurrence and metastasis, but this is not guaranteed.Conclusion
The goal of this report is to outline the current characteristics as-
sociated with the more malignant type of SFTs in order to highlight
those less malignant type characteristics of our patient's tumor and
to allow physicians to better educate and prepare their patients
regarding prognosis and recovery of an SFT of the female genital
tract. Most of these tumors are benign, but some behave more aggres-
sively. Unfortunately, the correlation between pathologic grading
and clinical behavior is poor. A number of morphologic characteristics
and immunohistochemical proﬁles may help to more closely identify
a benign versus malignant SFT. However the data above indicates that
a complete surgical resection is imperative and careful follow up
should be the standard of care for these patients. In addition to com-
plete surgical resection, a complete histologic work up should be
performed including immunohistochemistry, but this should not pre-
clude patients from diligent follow up. The majority of these patients
should experience disease limited to the site of origin and limited
recurrence with complete initial surgical resection.Consent
Written informed consent was obtained from the patient for pub-
lication of this case report. A copy of the written consent is available
for review by the Editor-in-Chief of this journal on request.
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